Varian Medical Systems (VAR.NYSE) announced that the South Florida Proton Therapy Institute (SFPTI) has treated its first patient using the Varian ProBeam Compact single-room proton therapy system.
Cognetivity Neurosciences (CGN.C) has reached the threshold of participants in their clinical evaluation study of its integrated cognitive assessment (ICA) platform for dementia sufferers to register for CE marking.
Australia is a member of the assorted collection of countries with aging populations and an extreme shortage of doctor’s and nurses.
Oxycontin, once pitched as a treatment for chronic pain, is now synonymous with the opioids currently plaguing Canada and the United States.
VitalHub (VHI.V) recently partnered with the Government of Yukon following the territory’s request for assistance in upgrading and streamlining its mental health and substance use medical records system.
Three non-weed deals you don’t know: ParcelPal (PKG.C), Clear Blue (CBLU.V), and Titan Medical (TMD.T)
If I was getting paid by the number of pitches I hear, I’d be making a lot more money than I do. Often, they’re terrible. And I include ‘just okay’ in the terrible column, because if your investment pitch isn’t lights out amazing, it’s death.
A few years back, I wrote about Helius Medical Technologies (HSM.T), which I heard about from Fabrice Taylor, and liked a lot as a long term biotech play.
Back when it was dragging its ass along the road at $0.10 a share, we told you – again and again – that Reliq Health Technologies (RHT.V) was doing actual business with a big fat upside.